| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 21.59B | 27.10B | 28.33B | 36.25B | 25.96B |
| Gross Profit | 7.29B | 9.65B | 9.74B | 17.05B | 7.60B |
| EBITDA | 11.36B | 12.72B | 14.54B | 22.16B | 13.89B |
| Net Income | 2.37B | 3.04B | 4.67B | 13.22B | 2.31B |
Balance Sheet | |||||
| Total Assets | 84.19B | 85.44B | 74.01B | 72.61B | 75.04B |
| Cash, Cash Equivalents and Short-Term Investments | 1.97B | 2.13B | 1.43B | 984.00M | 2.76B |
| Total Debt | 1.77B | 27.10B | 20.91B | 20.77B | 30.39B |
| Total Liabilities | 47.59B | 50.97B | 43.66B | 42.52B | 54.71B |
| Stockholders Equity | 36.03B | 34.16B | 30.25B | 30.09B | 20.33B |
Cash Flow | |||||
| Free Cash Flow | 4.11B | 4.42B | 6.06B | 12.46B | 7.56B |
| Operating Cash Flow | 10.53B | 11.44B | 12.31B | 16.81B | 10.43B |
| Investing Cash Flow | -5.80B | -14.59B | -6.98B | -4.87B | -1.25B |
| Financing Cash Flow | -4.84B | 3.84B | -4.89B | -13.71B | -8.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $49.86B | 12.10 | 10.92% | 2.70% | 60.29% | -17.62% | |
78 Outperform | $66.34B | 12.17 | 18.48% | 3.79% | -5.15% | -19.06% | |
77 Outperform | $27.36B | 10.65 | 17.60% | 2.64% | 11.14% | -21.32% | |
74 Outperform | $34.63B | 12.04 | 8.33% | 6.85% | 15.31% | 58.83% | |
74 Outperform | $23.87B | 14.52 | 11.86% | 3.39% | 26.13% | 31.42% | |
72 Outperform | $46.41B | 29.26 | 6.86% | 2.39% | -2.48% | -65.26% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |
On February 19, 2026, Occidental Petroleum launched cash tender offers to repurchase up to $700 million in aggregate principal amount of several series of its outstanding senior notes and debentures, including a $58 million sub-cap for its zero coupon notes due 2036, with an expiration date of March 19, 2026. The offers feature an early tender deadline of March 4, 2026, early tender premiums, and settlement dates shortly after each deadline, with funding to come from cash on hand, including proceeds from the January 2, 2026 sale of Occidental Chemical Corporation and its subsidiaries.
In conjunction with the tender offers, Occidental is soliciting consents from holders of most of the targeted notes to approve amendments that would remove certain covenants from the governing indentures, contingent on achieving requisite consent levels. The transaction is designed to reduce and reshape Occidental’s debt profile while loosening some bond covenant restrictions, signaling continued balance sheet management following the divestiture of its chemical business and potentially improving financial flexibility for the company and its stakeholders.
The most recent analyst rating on (OXY) stock is a Buy with a $52.00 price target. To see the full list of analyst forecasts on Occidental Petroleum stock, see the OXY Stock Forecast page.
On January 2, 2026, Occidental completed the $9.7 billion all-cash sale of its chemical business, OxyChem, to Berkshire Hathaway, finalizing a divestiture first agreed in October 2025. The transaction is intended to accelerate Occidental’s strategy to strengthen its balance sheet and sharpen its focus on its higher-return oil and gas portfolio, while the company retains OxyChem’s legacy tort claims and certain environmental liabilities in a separate subsidiary that will continue funding and managing long-term remediation activities, a structure that preserves the operational value of the assets for the buyer while keeping historical risk obligations with Occidental.
The most recent analyst rating on (OXY) stock is a Hold with a $46.00 price target. To see the full list of analyst forecasts on Occidental Petroleum stock, see the OXY Stock Forecast page.